Call Now: (973) 630-2200 Make an Appointment

Published Work

  1. Adelman, S.J., Baldwin, H.E., et al.  Studies of normal and near normal main    sequence B and early A starts.  Bulletin of South Carolina Academy of Science. 1979;Vol. XLI, p.39.
  2. Adelman, S.J., Young, J.M. & Baldwin, H.E. Optical Region Elemental  Abundance Analysis of Band A stars-II.  The hot AM stars O Pegasi and Aquarii and the marginal peculiar A star concri.  Mon. Nat. Royal Astro Soc. 1984; 206:649-660.
  3. Baldwin, H.E., Geronemus, R.G. Treatment of Zoon’s balanitis with the carbon dioxide laser.  J Derm Surg & Oncol.  1989; 15(5):491-494.
  4. Baldwin, H.E., Lynfield, Y.L. Brunsting-Perry Cicatricial Pemphigoid precipitated by trauma.  Arch Dermatol. 1991; 127:911-912.
  5. Baldwin, H.E., Berck, C.M., Lynfield, Y.L. Subcutaneous Nodules of the Scalp:preoperative management.  J Am Acad Dermatol. 1991;25(5 Pt 1):819-30.
  6. Rabbin, P., Baldwin, H.E.  Treatment of porokeratosis of mibelli with CO2 laser vaporization vs surgical excision with split – thickness skin graft:  A comparison.  J Derm Surg and Oncol. 1993; 19(3):199-202.
  7. Kahn, M., Lynfield, Y.L., Baldwin, H.E.. Relapsing polychondritis: case report and review of the literature. Cutis. 1994: 54(2):98-100.
  8. Salvemini, J., Cande, F., Lynfield, Y., Baldwin, H.E. Multiple basal cell carcinomas induced by radiation therapy.  Arch Derm. 1995; Vol 131: 483-488.
  9. Salvemini, J., Baldwin, H.E Botryomycosis in a patient with Acquired Immunodeficiency Syndrome.  Cutis. 1995; 56:158-160.
  10. Leyden, J., Baldwin, H.E., Shalita, A.R., et al. Finasteride in the treatment of men with frontal male pattern hair loss.  J Amer Acad Dermatol. 1998; 40:930-7.
  11. Baldwin, H.E., Solomon, B., et al. LIVID: Lasting immunity to varicella in doctors.  J Amer Acad Dermatol. 1998; 38:763-5.
  12. Baldwin, H.E. Pathology and treatment of keloids.  Cos Dermatol. 1999; 12:26-30.
  13. Baldwin, H.E. Self-assessment examination of the American Academy of Dermatology.  J Amer Acad Dermatol. 2000; 42: 153-154 and 157-158.
  14. Baldwin, H.E. Self-Assessment examination of the American Academy of Dermatology:  Chromoblastomycosis.  J Amer Acad Dermatol.  2000; 43:159-160, 163.
  15. Hill, A.R., Silverberg, N.D., Mayorga, D., Baldwin, H.E. Medical Hazards o the Tear Gas CS: A case of persistent, multisystem, hypersensitivity reaction and review of the literature.  Medicine, 2000; 79:234-40.
  16. Baldwin, H.E. How to treat acne in people of color.  Skin & Aging. 2000; 8:48-57.
  17. Baldwin, H.E. What are the best resurfacing modalities for acne scars?  Skin & Aging.  2001; 9:44-50.
  18. Baldwin, H.E. Can filler substances improve acne scarring?  Skin & Aging. 2001; 9:50-56.
  19. Baldwin, H.E. General Herpes: Diagnosis and treatment.  Med Asp Human Sexual. 2001; 1:26-32.
  20. Baldwin, H.E. STD Update: Screening and therapeutic options.  Int. J. Fert. 2001; 46(2):79-88.
  21. Baldwin, H.E. Surgical revisions for acne scars.  Skin & Aging. 2001; 939-43.
  22. Baldwin, H.E. The interaction between acne vulgaris and the psyche. Cutis;. 2002; 70(2): 133-139
  23. Baldwin, H.E. Oral therapy for Rosacea  J Drugs Dermatol. 2006;5:16-21.
  24. Baldwin, H.E. Coping with the isotretinoin registry.  Dermatol Ther,  2005;19:241-50
  25. Baldwin, H.E. Tricks for improving compliance with acne therapy. Dermatol Ther J, 2005;19:224-36.
  26. Baldwin, H.E. Managing acne in skin of color.  Cos Dermatol, 2005.
  27. Baldwin, H.E. Systemic therapy for rosacea.  Skin Therapy Lett. 2007;12:1-5.
  28. Del Rosso, JQ, Baldwin, H.E., Webster, G; American Acne and Rosacea Society.  American Acne and Rosacea Society Rosacea Medication and Management Guidelines.  J Drugs Dermatol, 2008;7:531-3.
  29. Del Rosso, J.Q., Baldwin, H.E., Keri, J., Mancini, A., Gold, L.S., Webster, G.F. Current approach to acne management – a community-based analysis. Cutis 2009; 83(6 Suppl): 5-21.
  30. Baldwin, H.E. Prevention of keloids. In: Norman R.A., Ed. Preventative Dermatology. London: Springer-Verlag; 2010.
  31. Baldwin, H.E. Keloid management. In: Robinson J.K., Hanke, C.W., Siegel, D.M., Fratzla A. Eds. Mosby Elsevier, Edengurgh; 2010.
  32. Baldwin, H.E. A community-based study of the effectiveness of doxycycline 40mg (30mg immediate-release and 10mg delayed-release beads) on the quality of life and satisfaction with treatment in participants with rosacea. Cutis 2010; 86(5 Suppl): 26-36.
  33. Yan, A.C., Baldwin, H.E., Eichenfield, L.F., Friedlander, S.F., Mancini, A.J. Approach to pediatric acne treatment: an update. Semin Cutan Med Surg, 2011 Sep;30(3Suppl):S16-21.
  34. Friedlander, S.F., Baldwin, H.E., Mancini, A.J., Yan, A.C., Eichenfield, L.F. The acne continuum: an age-based approach to therapy.  Semin Cutan Med Surg. 2011 Sept;30(3 Suppl):S6-S11.
  35. Eichenfield L.F., Mancini, A.J., Yan, A.C., Friedlander, S.F., Baldwin, H.E. Parents as partners in pediatric acne management.  Semin Cutan Med Surg. 2011 Sept;30(3 Suppl):S22.
  36. Mancini, A.J., Baldwin, H.E., Eichenfield, L.F., Yan, A.C.  Acne life cycle: the spectrum of pediatric disease. Semin Cutan Med Surg. 2011 Sep;30(3 Suppl):S2-5.
  37. Baldwin HE, Nighland M, Kendall C, Mays DA, Grossman R, Newburger J.  40 years of topical tretinoin use in review. J Drug Dermatol. 2013 Jun 1;12(6):638-42.
  38. Eichenfield LF, Krakowski AC, Piggott C, Del Rosso J, Baldwin H, Friedlander SF, Levy M, Lucky A, Mancini AJ, Orlow SJ, Yan AC, Vaux KK, Webster G, Zaenglein AL, Thiboutot DM; American Acne and Rosacea Society. Evidence-based recommendations for the diagnosis and treatment of pediatric acne. Pediatrics. 2013 May;131 Suppl 3:S163-86. doi: 10.1542/peds.2013-0490B.
  39. Baldwin, HEIs it acne or is it rosacea? An important distinction.Cutis. 2012 Aug;90(2):59-61.
  40. Baldwin HE. Diagnosis and treatment of rosacea: state of the art.J Drugs Dermatol;11(6):725-30.
  41. Del Rosso JQ, Gallo RL, Kircik L, Thiboutot D, Baldwin HE, Cohen D.  Why is rosacea considered to be an inflammatory disorder? The primary role, clinical relevance, and therapeutic correlations of abnormal innate immune response in rosacea-prone skin. J Drugs Dermatol. 2012 Jun;11(6):694-700.
  42. Baldwin H, Berson D, Vitale M, et al.  Clinical effects of a novel topical composition on persistent redness observed in patients who had been successfully treated with topic or oral therapy for papulopustular rosacea.  J Drugs Dermatol.  2014 Mar, 13(3):326-31.
  43. Baldwin H, Kawata A, Daniels S, Wilcox T, Burk C, Tanghetti E.  Impact of Female Acne on Patterns of Health Care Resource Utilization.  J Drugs Dermatol 2015;14(2): 140-150.
  44. Baldwin H.  Treating Acne During Pregnancy and Lactation.  Cutis.  2015;96(1):11-12.
  45. Baldwin H.  Reframing the Isotretinoin Discussion.  Sem Cut Med Surg.  2015;34(5S):S81.
  46. Baldwin H, Zaenglein, Leyden J, Webster G.  Pharmacologic Treatment Options in Mild, Moderate, and Severe Acne Vulgaris.  Sem Cut Med Surg. 2015;34(5S):S82-S85.
  47. Webster G, Leyden J, Baldwin H, Zaenglein A.  Isotretinoin: Mechanism of Action and Patient Selection.  Sem Cut Med Surg.  2015;34(5S):S86-S88.
  48. Leyden J, Webster G, Zaenglein A, Baldwin H.  Understanding and Reducing the Risk for Acne Scarring.  Sem Cut Med Surg.  2015;34(5S):S80-S91.
  49. Zaenglein A, Baldwin H, Webster G, Leyden J.  Psychosocial Issues in Acne Management: Disease Burden, Treatment Adherence and Patient Support.  Sem Cut Med Surg.  2015;34(5S): S92-S94.
  50. Baldwin, HE.  Pharmacologic Treatment Options in Mild, Moderate, and Severe Acne Vulgaris.  Semin Cutan Med Surg. 2015 Sep:34(5S):S82-S85.
  51. Zaenglein AL, Pathy AL, Schlosser BJ, AilikhanA, Baldwin HE, et al.  Guidelines of Care for the Management of Acne Vulgaris.  J Am Acad Dermatol. 2016 Feb 15 (Epub ahead of print).

 

Book Chapters

  1. Sohn, H.G., Turk, H.B., Baldwin, H.E. Dermatologic Problems.  In Essentials of Otolaryngology.  1999.  Lucente, F.E., & Har-El, G. Eds. 4th Ed. Lippincott Williams and Williams, Philadelphia.
  2. Koo, J., Kee, C., Kestenbaum, T., Ginsburg, I. Baldwin, H.E., et al.  International consensus on care of psychodermatologic patients, Ch. 3. In Koo, J.M., Lee, C.S. Eds. Psychocutaneous Medicine, New York: Marcel Dekker, 2004, 31-40.
  3. Baldwin, H.E. Dermatologic Disorders In Essentials of Otolaryngology. 2004. Lucente, F.E., & Har-El, G. Eds.  5th Ed.  Lippincott  and Williams, Philadelphia.
  4. Baldwin, H.E. Keloid Management. In Surgery of the Skin. Robinson, J. Henke, C., Sengelmann, R., Siegel, D., Eds.  Elsevier, London.  2005, 705-718.
  5. Baldwin, H.E. Keloid Management.  In Surgery of the Skin: Procedural Dermatology.  Robinson, J. Henke, C, Siegel, D, Fratila A., Eds.  Elsevier, London.  2010: 669-682.
  6. Baldwin, H.E. Prevention of Keloids.  In Preventive Dermatology.  Norman, R Ed.  Springer. 2013, p 281-292.
  7. Baldwin, H.E., Integrative Management of Rosacea.  In Integrative Dermatology.  Norman R, Shenefelt P, Rupani R, eds.  Oxford University Press, London.  2014, p. 390-415.
  8. Baldwin, H.E. Neonatal and Infantile Acne.  In Acneiform Eruptions in Dermatology: A Differential Diagnosis.  Zeichner, J Ed.   Springer 2014. Pp.371-374.